Cortex Pharmaceuticals, Inc. Reports Second Quarter Operating Results

IRVINE, Calif.--(BUSINESS WIRE)--Cortex Pharmaceuticals, Inc. (OTCBB: CORX) reported a net loss of approximately $356,000, or $0.00 per share, for the quarter ended June 30, 2011, compared with a net loss of approximately $2,454,000, or $0.04 per share, for the corresponding prior year period, with the difference reflecting revenues in the current year period from the Company’s option agreement with Servier, France’s largest privately held pharmaceutical company.

MORE ON THIS TOPIC